Lintbells

About  

Inflexion invested in Lintbells, a globally recognised leader in pet supplements in 2017, before selling it in 2024 to Vetnique Labs, backed by Gryphon Investors.   

Hertfordshire, UK-based Lintbells was founded almost two decades ago by Dr John Howie DL and John Davies, to provide pets and their owners with scientifically supported supplements to support chronic health conditions. Lintbells’ products are sold under the YuMOVE brand umbrella, encompassing the UK’s number one joint mobility supplement for dogs and cats, as well as supplements to support digestive health, anxiety, skin & coat and dental.

Value acceleration   

Since the 2017 investment, Inflexion has supported Lintbells in several key areas, including expanding its direct-to-consumer channel and facilitating its entry into the US market, both organically and through acquiring Walkin’ Pets.

Inflexion also assisted Lintbells in achieving B Corp accreditation, highlighting its ESG accomplishments. Additionally, they facilitated the planned succession of Co-founder John Howie, with Fiona Hope joining as Chief Commercial Officer and becoming CEO in 2022.